Presentation
17 March 2023 Dual-excitation multispectral autofluorescence lifetime endoscopy for clinical label-free metabolic imaging of oral lesions
Author Affiliations +
Abstract
We report a new approach for label-free metabolic imaging of oral lesions using a novel fluorescence lifetime imaging endoscopy (FLIMEnd) system. The FLIMEnd system is capable of simultaneous dual-wavelength excitation and fluorescence detection at four emission spectral bands. Preliminary results indicate that established metabolic autofluorescence biomarkers of oral pre-malignancy and malignancy can be clinically imaged with this novel FLIMEnd technology. Future work will focus on identifying both established and novel autofluorescence biomarkers of oral pre-cancer and cancer that can be used to develop machine-learning driven FLIMEnd systems for early detection of oral cancer.
Conference Presentation
© (2023) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Rodrigo Cuenca Martinez, Michael J. Serafino, Gabriel P. Tortorelli, Ronald C. Faram, Kathleen E. Higgins, Sharukh S. Khajotia, Yi-Shing L. Cheng, Jacqueline M. Plemons, Victoria Woo, Carlos Busso Recabarren, Kayla R. Caughlin, and Javier A. Jo "Dual-excitation multispectral autofluorescence lifetime endoscopy for clinical label-free metabolic imaging of oral lesions", Proc. SPIE 12354, Imaging, Therapeutics, and Advanced Technology in Head and Neck Surgery and Otolaryngology 2023, 1235409 (17 March 2023); https://doi.org/10.1117/12.2647972
Advertisement
Advertisement
KEYWORDS
Endoscopy

Cancer

Imaging systems

Fluorescence lifetime imaging

Fluorescence spectroscopy

Image resolution

Luminescence

Back to Top